EVGN · Evogene Ltd.
Market Cap
$8.68M
Shares
15.80M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-27 | — | |
| 6-K | 2026-08-18 | — | |
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-17 | — | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-06-11 | — | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-04-02 | — | |
| 20-F | 2026-03-26 | 2025-12-31 | |
| 6-K | 2026-03-05 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-11 | — | |
| 6-K | 2026-02-04 | — | |
| 6-K | 2026-01-15 | — | |
| 6-K | 2025-12-30 | — | |
| 6-K | 2025-11-20 | — | |
| 6-K | 2025-09-30 | 2025-06-30 | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-08-19 | — | |
| 6-K | 2025-08-18 | — | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-07-17 | — | |
| 6-K | 2025-07-08 | — | |
| 6-K | 2025-06-17 | — | |
| 6-K | 2025-06-05 | — | |
| 6-K | 2025-05-21 | — | |
| 6-K | 2025-04-21 | — | |
| 20-F | 2025-03-27 | 2024-12-31 | |
| 6-K | 2025-03-06 | — | |
| 6-K | 2025-03-06 | — | |
| 6-K | 2025-02-12 | — | |
| 6-K | 2025-02-05 | — | |
| 6-K | 2025-01-15 | — | |
| 6-K | 2024-12-30 | — | |
| 6-K | 2024-11-27 | — | |
| 6-K | 2024-11-21 | — | |
| 6-K | 2024-09-17 | — | |
| 6-K | 2024-09-16 | 2024-06-30 | |
| 6-K | 2024-08-23 | — | |
| 6-K | 2024-08-22 | — | |
| 6-K | 2024-08-12 | — | |
| 6-K | 2024-07-23 | — | |
| 6-K | 2024-06-25 | — | |
| 6-K | 2024-06-20 | — | |
| 6-K | 2024-06-17 | — | |
| 6-K | 2024-06-06 | — | |
| 6-K | 2024-05-29 | 2024-05-31 | |
| 6-K | 2024-05-23 | — | |
| 6-K | 2024-05-23 | — |
Showing 1–50 of 172 filings